CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,138 | 7,971 | ||
| 2023-09-06 | AFEYAN NOUBAR Director | Sale 10b5-1 | −9,011 | $107.27 | $967K | 1,988,198 |
| 2023-09-06 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,689 | $108.07 | $615K | 1,982,509 |
| 2023-09-06 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $108.91 | $33K | 1,982,209 |
| 2023-09-06 | Garay Arpa Chief Commercial Officer | Sale 10b5-1 | −574 | $108.40 | $62K | 3,113 |
| 2023-09-05 | Garay Arpa Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,140 | 3,687 | ||
| 2023-09-05 | Garay Arpa Chief Commercial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,140 | 12,546 | ||
| 2023-09-05 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −115 | $111.44 | $13K | 6,634 |
| 2023-09-05 | Hoge Stephen President | Sale 10b5-1 | −320 | $111.44 | $36K | 1,589,187 |
| 2023-09-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +233 | 6,749 | ||
| 2023-09-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −233 | 2,326 | ||
| 2023-09-01 | Hoge Stephen President | Exercise or conversion 10b5-1 | +652 | 1,589,507 | ||
| 2023-09-01 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −652 | 6,516 | ||
| 2023-08-30 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,847 | $114.64 | $670K | 2,006,362 |
| 2023-08-30 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,717 | $115.43 | $544K | 2,001,645 |
| 2023-08-30 | AFEYAN NOUBAR Director | Sale 10b5-1 | −4,336 | $116.57 | $505K | 1,997,309 |
| 2023-08-30 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $117.21 | $12K | 1,997,209 |
| 2023-08-29 | Hoge Stephen President | Sale 10b5-1 | −1,135 | $115.01 | $131K | 1,588,855 |
| 2023-08-28 | Hoge Stephen President | Exercise or conversion 10b5-1 | +2,411 | 1,589,990 | ||
| 2023-08-28 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,411 | 4,822 |
Page 39 of 66 · 1,314 trades